NR1I3 and hepatocellular carcinoma: Additionally, our findings also verified that NR1I3 was targeted and negatively regulated by miR‐211‐5p, and demonstrated low expression of NR1I3 in HBV+ HCC tissues and HepG2.2.15 cells.